A Patient’s Guide to Depression and Anxiety Medications: SSRIs, SNRIs, Wellbutrin, and Beyond
If your doctor has suggested medication for depression or anxiety, your next move is probably a late-night search: which antidepressant has the fewest side effects? Does Wellbutrin cause weight gain? Is Lexapro or Zoloft better for anxiety? The list of drug names is long, the information online is contradictory, and it is genuinely hard to know where to start.
Here is the reassuring truth: most antidepressants work about equally well for the average person. The real art is matching the right medication to your specific symptoms, your other health conditions, and the side effects you most want to avoid. There is no single best antidepressant, but there is very likely a best one for you.
This guide is a plain-language tour of the main medication families used for depression and anxiety. The goal is not for you to diagnose or prescribe for yourself. Only a licensed clinician can do that safely. It is to walk into your appointment informed, so the conversation is a partnership. A few themes apply to almost every medication below, so keep them in mind as you read:
- They take time. Most antidepressants take 2 or more weeks to begin working and up to 2 to 3 months for full effect.
- Early side effects often fade. Nausea, headache, or jitteriness are most common in the first week or two and frequently settle down.
- Stopping abruptly can cause withdrawal. Many of these medications should be tapered under medical guidance, never stopped cold turkey.
- There is a suicide-risk warning for young people. In those under 25, antidepressants carry a small increased risk of suicidal thoughts, especially in the first few weeks, which is why close monitoring early on matters.
SSRIs: The Usual Starting Point
Selective serotonin reuptake inhibitors (SSRIs) increase the availability of serotonin, a brain chemical involved in mood and anxiety. They are the most commonly prescribed first-line treatment for both depression and anxiety because they are effective and generally well tolerated.
- Escitalopram (Lexapro): Often a first choice; FDA-approved for both depression and generalized anxiety disorder. Frequently favored for a relatively clean side-effect profile.
- Sertraline (Zoloft): Very versatile; approved for depression, panic disorder, social anxiety, OCD, PTSD, and PMDD. A common go-to when anxiety is part of the picture.
- Fluoxetine (Prozac): Long-acting, which makes it more forgiving if a dose is missed and lowers withdrawal risk. Approved for depression, panic disorder, OCD, bulimia, and PMDD; can be more activating.
- Paroxetine (Paxil): Effective for several anxiety disorders, but more prone to sedation, weight gain, and withdrawal symptoms; generally avoided in older adults.
- Citalopram (Celexa): Effective and generally well tolerated, but has a dose ceiling because higher doses can affect heart rhythm (QT prolongation).
- Fluvoxamine (Luvox): Primarily used for OCD and anxiety.
Common SSRI side effects: nausea, headache, insomnia or drowsiness, and sexual side effects, including lowered libido and difficulty reaching orgasm. Nausea and headache usually improve within a couple of weeks; sexual side effects can persist and are worth discussing openly. Less commonly, SSRIs can increase bleeding risk and, in older adults, lower sodium levels.
SNRIs: When Serotonin Plus Norepinephrine Helps
Serotonin-norepinephrine reuptake inhibitors (SNRIs) act on two brain chemicals, serotonin and norepinephrine. This dual action can be useful when depression comes with fatigue and low energy, or when chronic pain is also present. They are also first-line options for anxiety.
- Venlafaxine (Effexor XR): Approved for depression, generalized anxiety, social anxiety, and panic disorder. Effective, but more likely to raise blood pressure at higher doses and is well known for withdrawal symptoms if stopped abruptly.
- Duloxetine (Cymbalta): A strong choice when pain and depression or anxiety coexist. Also approved for diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain, as well as generalized anxiety.
- Desvenlafaxine (Pristiq): A close relative of venlafaxine with simple dosing and fewer drug interactions; may be gentler for some people. Often associated with less sexual dysfunction.
- Levomilnacipran (Fetzima): Approved for depression; may help with energy and motivation, with generally fewer gastrointestinal and sexual side effects.
Common SNRI side effects: nausea, dry mouth, sweating, insomnia, and, especially at higher doses, increased blood pressure and heart rate. Because of the blood-pressure effect, monitoring is recommended. Like SSRIs, they can cause sexual side effects and withdrawal symptoms if stopped suddenly.
Bupropion (Wellbutrin): The “Different” Antidepressant
Bupropion works on dopamine and norepinephrine rather than serotonin, which gives it a distinctive profile that many patients specifically ask about.
- What it is good for: Depression, especially when fatigue, low motivation, or trouble concentrating are prominent. It is also FDA-approved for smoking cessation and seasonal depression, and is sometimes added to an SSRI or SNRI.
- The two big draws: It is generally not associated with sexual side effects, and it tends to be weight-neutral rather than causing weight gain, the two complaints that most often drive people off other antidepressants.
- Important cautions: Bupropion can be activating and may worsen anxiety or insomnia in some people, so it is often not a first pick when anxiety is the main problem. It carries a small increased seizure risk and should not be used in people with a seizure disorder or active eating disorder (bulimia or anorexia).
Common side effects: dry mouth, insomnia, headache, nausea, tremor, and jitteriness.
Mirtazapine (Remeron): Helpful When Sleep and Appetite Are the Problem
Mirtazapine works differently from the others and has a niche it fills especially well.
- What it is good for: Depression accompanied by insomnia, poor appetite, or weight loss. Its most prominent effects, sedation and increased appetite, can be turned into advantages when those symptoms are present. It is usually taken at bedtime and is sometimes combined with an SSRI or SNRI.
- A notable plus: It is associated with less sexual dysfunction than SSRIs and SNRIs.
- The trade-off: The same properties that help sleep and appetite mean drowsiness and weight gain are the main downsides, so it is typically avoided when weight gain is a concern.
Common side effects: drowsiness, increased appetite and weight gain, dry mouth, and dizziness.
Newer “Multimodal” Options: Vortioxetine and Vilazodone
These newer medications act on serotonin in more complex ways and are often chosen for specific reasons.
- Vortioxetine (Trintellix): Approved for depression and frequently chosen when depression comes with brain fog or difficulty concentrating, as it may help with these cognitive symptoms. It may also carry a somewhat lower risk of sexual side effects. Its most common side effect is nausea, usually mild, most intense in the first week, and typically fading over about two weeks; constipation and vomiting can also occur.
- Vilazodone (Viibryd): Approved for depression and associated with less sexual dysfunction than traditional SSRIs. It must be taken with food to work properly. The most common side effects are diarrhea, nausea, and insomnia.
Trazodone: Often Used for Sleep
Trazodone is technically an antidepressant, but at the low doses most people receive it is used off-label as a sleep aid rather than as a primary depression treatment. Its main effect is drowsiness; other side effects include dizziness and dry mouth.
A Quick Word on Older Classes
You may come across tricyclic antidepressants (TCAs, such as nortriptyline) and monoamine oxidase inhibitors (MAOIs). These are effective but carry more risk and require more caution, including dietary and drug restrictions with MAOIs, so they are generally reserved for situations where newer medications have not worked. If your treatment ever heads in this direction, it is typically managed by or in consultation with a psychiatric specialist.
How Your Provider Chooses (and Why It Is Personalized)
Since these medications have broadly similar odds of working, the choice comes down to fit. Your prescriber weighs things like:
- Your target symptoms: Low energy and fatigue may point toward an SNRI or bupropion; insomnia and poor appetite toward mirtazapine; brain fog toward vortioxetine; coexisting anxiety toward an SSRI or SNRI.
- Side effects you most want to avoid: Worried about sexual side effects or weight gain? Bupropion, mirtazapine, vortioxetine, vilazodone, and desvenlafaxine are often part of that conversation.
- Other health conditions: Chronic pain, high blood pressure, heart rhythm issues, seizure history, and age all shape the safest choice.
- Your history and preferences: What has worked for you, or a close relative, before, cost and insurance coverage, and how often you want to take a pill.
Finding the right medication is sometimes a process of adjustment rather than a single perfect first pick, and that is normal, not a failure. If the first choice is not a good fit, switching or fine-tuning is a routine and expected part of good care.
Choosing a medication for depression or anxiety should not feel like a guessing game you play alone at 2 a.m. You deserve a prescriber who takes the time to understand your symptoms, your lifestyle, and your concerns, and who treats medication as one carefully personalized tool, not a one-size-fits-all fix.
Ready to explore your options?
Alice Tran, PMHNP-BC, provides psychiatric evaluations, medication management, and supportive therapy, in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. No referral needed.
Schedule a ConsultationSee Also
Sources
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. View
- Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3, Pharmacological Treatments. Canadian Journal of Psychiatry. 2016;61(9):540-560. View
- Szuhany KL, Simon NM. Anxiety Disorders: A Review. JAMA. 2022;328(24):2431-2445. View
- Stein MB, Sareen J. Generalized Anxiety Disorder. The New England Journal of Medicine. 2015;373(21):2059-68. View
- Patel K, Allen S, Haque MN, et al. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Therapeutic Advances in Psychopharmacology. 2016;6(2):99-144. View
- Watanabe N, Omori IM, Nakagawa A, et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews. 2011;(12):CD006528. View
- Baldwin DS, Chrones L, Florea I, et al. The safety and tolerability of vortioxetine: analysis of data from randomized placebo-controlled trials and open-label extension studies. Journal of Psychopharmacology. 2016;30(3):242-52. View
- Jaffer KY, Chang T, Vanle B, et al. Trazodone for Insomnia: A Systematic Review. Innovations in Clinical Neuroscience. 2017;14(7-8):24-34. View
- Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychotherapy and Psychosomatics. 2015;84(2):72-81. View
Medical Disclaimer
The information in this article is for educational purposes only and does not constitute medical advice. It is not a recommendation for any specific medication. Antidepressants should never be started, stopped, or changed without direct guidance from a licensed prescriber, as abrupt discontinuation can cause withdrawal effects and some medications carry important warnings. Only a licensed professional can accurately diagnose and treat depression and anxiety disorders.
Anh Tran (Alice), PMHNP-BC, FNP-BC
Dual Board-Certified Family and Psychiatric Nurse Practitioner
Alice is a dual board-certified PMHNP and FNP licensed in Virginia, trained under psychiatrist Dr. Errol Segall, MD (50+ years of experience). She treats ADHD, anxiety, depression, and more, in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. Learn more →